Evaluating Buspirone to Treat Opioid Withdrawal

Abroad (travel likely)RecruitingPHASE2

Conditions

Opioid Use Disorder · Opioid Withdrawal · Opioid Craving · Anxiety

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Kahlert Institute for Addictino Medicin, Baltimore, Maryland, United States
Contact: Study coordinator (Cecilia Bergeria, Ph.D.) · cberge21@jhmi.edu · 410-550-1979
Contact: Principal Investigator (Cecilia Bergeria, Ph.D.)

Study leads

Cecilia Bergeria, Ph.D.
Principal Investigator
Johns Hopkins University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

CEDRN: Opioid Registry

Opioid Use Disorder · Opioid Abuse or Dependence · Opioid Withdrawal

Abroad (travel likely)Recruiting

Vancouver, Canada

Developing a Clinical Outcome Assessment for Opioid Craving

Opioid Craving · Opioid Use Disorder · Measure Development

Abroad (travel likely)Recruiting

Baltimore, United States

Evaluation of a Physical Device for Medical Use (ADTPM 1) for Opioid Withdrawal Symptoms

Opioid Withdrawal (Disorder) · Opioid Use Disorder

Abroad (travel likely)Recruiting

Daegu, South Korea

A Study of Brenipatide in Participants With Opioid Use Disorder

Opioid Use Disorder

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Little Rock, United States